ARCHIVES

DCE Advisors OK Recompetitions Worth $10 Mil.

This article is from The Cancer Letter archive.

Vol. 17 No. 29 | July 19, 1991

Download PDF Visit The Full Archive

Related Articles

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

White House Says Upton Appointment Due In Two Weeks

July 29, 1977